Chronic heart failure - Impact of the condition on patients and
the healthcare system in the Czech Republic: A retrospective
cost-of-illness analysis

J 2018

Chronic heart failure - Impact of the condition on patients and the healthcare system in the Czech Republic: A retrospective cost-of-illness analysis

PAVLUŠOVÁ, Marie, Jiří KLIMES, Jindřich ŠPINAR, Kamil ZEMAN, Jiří JARKOVSKÝ et. al.

Základní údaje

Originální název

Chronic heart failure - Impact of the condition on patients and the healthcare system in the Czech Republic: A retrospective cost-of-illness analysis

Autoři

PAVLUŠOVÁ, Marie (203 Česká republika, domácí), Jiří KLIMES (203 Česká republika), Jindřich ŠPINAR (203 Česká republika, domácí), Kamil ZEMAN (203 Česká republika), Jiří JARKOVSKÝ (203 Česká republika, domácí), Klára BENEŠOVÁ (203 Česká republika, domácí), Roman MIKLÍK (203 Česká republika, domácí), Ludmila POHLUDKOVÁ (203 Česká republika), Marián FELŠŐCI (703 Slovensko, domácí), Věra VESELÁ (203 Česká republika), Michaela BLAHOVCOVÁ (203 Česká republika), Filip DOSTÁL (203 Česká republika), Richard VONKA (203 Česká republika) a Jiří PAŘENICA (203 Česká republika, garant, domácí)

Vydání

cor et Vasa, AMSTERDAM, ELSEVIER SCIENCE BV, 2018, 0010-8650

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30201 Cardiac and Cardiovascular systems

Stát vydavatele

Nizozemské království

Utajení

není předmětem státního či obchodního tajemství

Kód RIV

RIV/00216224:14110/18:00104146

Organizační jednotka

Lékařská fakulta

DOI

http://dx.doi.org/10.1016/j.crvasa.2018.03.002

UT WoS

000433252900003

Klíčová slova anglicky

Chronic heart failure; Hospitalization costs; Cost-of-illness

Štítky

14110211, 14119612, rivok

Příznaky

Mezinárodní význam, Recenzováno

Změněno: 10. 2. 2019 13:47, Soňa Böhmová

Anotace

V originále

Background: The number of patients with heart failure is steadily increasing, as are the costs of their treatment. Nearly 70% of the costs associated with the treatment of heart failure are direct medical costs, and 70-80% of these are spent on hospitalizations. The aim of our study is to describe the all-cause hospitalization costs of patients with chronic heart failure (chronic HF) from the perspective of the healthcare system in the Czech Republic. Methods: In total, 1274 consecutively collected patients discharged in a stable condition from hospitalization for acute heart failure (= index hospitalization) from 2006 to 2012 were followed-up for 2 years. Their all-cause mortality and all-cause hospitalizations were retrospectively evaluated. The in-patient costs were calculated based on the relative weights of DRG codes for particular hospitalization events and on the basic DRG tariff for 2013 (CZK 28,898). Results: At the end of the 2-year follow-up, a total of 1511 hospitalizations were recorded. A total of 31.8% of patients survived without any hospitalization, 32.1% of patients survived with at least one hospitalization, and 36.1% of patients died. Re-hospitalizations for acute heart failure accounted for 31.2% of all cases. The average cost for one chronic HF patient hospitalized for any reason was CZK 85,414; the cost for acute heart failure re-hospitalization was CZK 31,320 during the 2-year follow-up period. The cost of all-cause hospitalizations within the first year after the index hospitalization was higher compared to the cost during the second year (CZK 58,528/year vs. CZK 23,082/year). As the estimated number of chronic HF patients is 230,000 (data from the Institute of Health Information and Statistics of the Czech Republic), we can calculate the total cost of all-cause hospitalizations of chronic HF patients to be approximately CZK 7.98 billion per year in the Czech Republic. Conclusion: The data from clinical practice confirm that patients with chronic HF discharged from acute heart failure hospitalization are at high risk of death and/or subsequent hospitalization. The average annual costs for all-cause hospitalizations of CHS patients within the first and second years are CZK 58,528 and CZK 23,082 per patient, respectively. The costs attributed to all-cause hospitalization care of chronic HF patients can be estimated as approximately 7.7% of all annual inpatient expenses of health insurance companies and 2.7% of total healthcare expenditures in the Czech Republic. (C) 2018 The Czech Society of Cardiology. Published by Elsevier Sp. z o.o. All rights reserved.

Návaznosti

MUNI/A/1250/2017, interní kód MU

Název: Validace Rule-out/rule-in protokolu u pacientů s bolestí na hrudi – pokračování v prospektivní studii

Investor: Masarykova univerzita, Validace Rule-out/rule-in protokolu u pacientů s bolestí na hrudi – pokračování v prospektivní studii, DO R. 2020_Kategorie A - Specifický výzkum - Studentské výzkumné projekty

Citovat

PAVLUŠOVÁ, Marie, Jiří KLIMES, Jindřich ŠPINAR, Kamil ZEMAN, Jiří JARKOVSKÝ, Klára BENEŠOVÁ, Roman MIKLÍK, Ludmila POHLUDKOVÁ, Marián FELŠŐCI, Věra VESELÁ, Michaela BLAHOVCOVÁ, Filip DOSTÁL, Richard VONKA a Jiří PAŘENICA. Chronic heart failure - Impact of the condition on patients and the healthcare system in the Czech Republic: A retrospective cost-of-illness analysis. cor et Vasa. AMSTERDAM: ELSEVIER SCIENCE BV, 2018, roč. 60, č. 3, s. "E224"-"E233", 10 s. ISSN 0010-8650. Dostupné z: https://dx.doi.org/10.1016/j.crvasa.2018.03.002.

@article{1453816,
   author = {Pavlušová, Marie and Klimes, Jiří and Špinar, Jindřich and Zeman, Kamil and Jarkovský, Jiří and Benešová, Klára and Miklík, Roman and Pohludková, Ludmila and Felšőci, Marián and Veselá, Věra and Blahovcová, Michaela and Dostál, Filip and Vonka, Richard and Pařenica, Jiří},
   article_location = {AMSTERDAM},
   article_number = {3},
   doi = {http://dx.doi.org/10.1016/j.crvasa.2018.03.002},
   keywords = {Chronic heart failure; Hospitalization costs; Cost-of-illness},
   language = {eng},
   issn = {0010-8650},
   journal = {cor et Vasa},
   title = {Chronic heart failure - Impact of the condition on patients and the healthcare system in the Czech Republic: A retrospective cost-of-illness analysis},
   volume = {60},
   year = {2018}
}

TY  - JOUR
ID  - 1453816
AU  - Pavlušová, Marie - Klimes, Jiří - Špinar, Jindřich - Zeman, Kamil - Jarkovský, Jiří - Benešová, Klára - Miklík, Roman - Pohludková, Ludmila - Felšőci, Marián - Veselá, Věra - Blahovcová, Michaela - Dostál, Filip - Vonka, Richard - Pařenica, Jiří
PY  - 2018
TI  - Chronic heart failure - Impact of the condition on patients and the healthcare system in the Czech Republic: A retrospective cost-of-illness analysis
JF  - cor et Vasa
VL  - 60
IS  - 3
SP  - "E224"-"E233"
EP  - "E224"-"E233"
PB  - ELSEVIER SCIENCE BV
SN  - 00108650
KW  - Chronic heart failure
KW  - Hospitalization costs
KW  - Cost-of-illness
N2  - Background: The number of patients with heart failure is steadily increasing, as are the costs of their treatment. Nearly 70% of the costs associated with the treatment of heart failure are direct medical costs, and 70-80% of these are spent on hospitalizations. The aim of our study is to describe the all-cause hospitalization costs of patients with chronic heart failure (chronic HF) from the perspective of the healthcare system in the Czech Republic. Methods: In total, 1274 consecutively collected patients discharged in a stable condition from hospitalization for acute heart failure (= index hospitalization) from 2006 to 2012 were followed-up for 2 years. Their all-cause mortality and all-cause hospitalizations were retrospectively evaluated. The in-patient costs were calculated based on the relative weights of DRG codes for particular hospitalization events and on the basic DRG tariff for 2013 (CZK 28,898). Results: At the end of the 2-year follow-up, a total of 1511 hospitalizations were recorded. A total of 31.8% of patients survived without any hospitalization, 32.1% of patients survived with at least one hospitalization, and 36.1% of patients died. Re-hospitalizations for acute heart failure accounted for 31.2% of all cases. The average cost for one chronic HF patient hospitalized for any reason was CZK 85,414; the cost for acute heart failure re-hospitalization was CZK 31,320 during the 2-year follow-up period. The cost of all-cause hospitalizations within the first year after the index hospitalization was higher compared to the cost during the second year (CZK 58,528/year vs. CZK 23,082/year). As the estimated number of chronic HF patients is 230,000 (data from the Institute of Health Information and Statistics of the Czech Republic), we can calculate the total cost of all-cause hospitalizations of chronic HF patients to be approximately CZK 7.98 billion per year in the Czech Republic. Conclusion: The data from clinical practice confirm that patients with chronic HF discharged from acute heart failure hospitalization are at high risk of death and/or subsequent hospitalization. The average annual costs for all-cause hospitalizations of CHS patients within the first and second years are CZK 58,528 and CZK 23,082 per patient, respectively. The costs attributed to all-cause hospitalization care of chronic HF patients can be estimated as approximately 7.7% of all annual inpatient expenses of health insurance companies and 2.7% of total healthcare expenditures in the Czech Republic. (C) 2018 The Czech Society of Cardiology. Published by Elsevier Sp. z o.o. All rights reserved.
ER  -

PAVLUŠOVÁ, Marie, Jiří KLIMES, Jindřich ŠPINAR, Kamil ZEMAN, Jiří JARKOVSKÝ, Klára BENEŠOVÁ, Roman MIKLÍK, Ludmila POHLUDKOVÁ, Marián FELŠ$\backslash$H OCI, Věra VESELÁ, Michaela BLAHOVCOVÁ, Filip DOSTÁL, Richard VONKA a Jiří PAŘENICA. Chronic heart failure - Impact of the condition on patients and the healthcare system in the Czech Republic: A retrospective cost-of-illness analysis. \textit{cor et Vasa}. AMSTERDAM: ELSEVIER SCIENCE BV, 2018, roč.~60, č.~3, s.~''E224''-''E233'', 10 s. ISSN~0010-8650. Dostupné z: https://dx.doi.org/10.1016/j.crvasa.2018.03.002.

Podrobný výpis o publikaci